Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRKD3 | O94806 | 3/20 | 0.48 |
| ▸ | MAP4K4 | O95819 | 3/20 | 0.48 |
| ▸ | MAPK9 | P45984 | 3/20 | 0.48 |
| ▸ | CSNK1A1 | P48729 | 3/20 | 0.48 |
| ▸ | CSNK1D | P48730 | 3/20 | 0.48 |
| ▸ | MINK1 | Q8N4C8 | 3/20 | 0.48 |
| ▸ | CSNK1G2 | P78368 | 2/20 | 0.48 |
| ▸ | CSNK1G3 | Q9Y6M4 | 2/20 | 0.48 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.48 |
| ▸ | GSK3B | P49841 | 1/20 | 0.48 |
| ▸ | MET | P08581 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.36 |
| ▸ | DYRK1A | Q13627 | 1/20 | 0.36 |
| ▸ | TAOK1 | Q7L7X3 | 1/20 | 0.36 |
| ▸ | PBK | Q96KB5 | 1/20 | 0.36 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.36 |
| ▸ | MAP4K5 | Q9Y4K4 | 1/20 | 0.36 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.35 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3724533 | 0.83 | MAP4K4 (0.46) | PRKD3MAP4K4MAPK9CSNK1A1CSNK1D | |
| SCHEMBL3524359 | 0.83 | NPC1 (0.47) | PRKD3MAP4K4MAPK9CSNK1A1CSNK1D | |
| SCHEMBL3523202 | 0.77 | KMO (0.40) | ADORA2AADORA1TGFBR1KMOF2RL3 | |
| SCHEMBL3242198 | 0.77 | MAPK9 (0.42) | PRKD3MAP4K4MAPK9CSNK1A1CSNK1D | |
| SCHEMBL13368329 | 0.73 | KMO (0.51) | MAPK9CSNK1A1CSNK1DMAPK8GSK3B | |
| SCHEMBL3663945 | 0.70 | MAPK9 (0.68) | PRKD3MAP4K4MAPK9CSNK1A1CSNK1D | |
| SCHEMBL3528770 | 0.70 | ALPL (0.47) | KMOF2RL3PDE3BPDE3A | |
| SCHEMBL3524337 | 0.69 | MAPK9 (0.66) | PRKD3MAP4K4MAPK9CSNK1A1CSNK1D | |
| SCHEMBL3527167 | 0.66 | PDE3B (0.49) | DYRK1AADORA2AADORA1TGFBR1KMO | |
| SCHEMBL3529079 | 0.65 | NPC1 (0.51) | METADORA2AADORA1TGFBR1TP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7709468-B2 | Imidazo based heterocycles | ABBOTT LABORATORIES (US) | 2010-05-04 | — | — | US | disclosed |
| US-7709468-B2 | Imidazo based heterocycles | ABBOTT LABORATORIES (US) | 2010-05-04 | — | — | US | disclosed |
| EP-2139329-A1 | NOVEL IMIDAZO BASED HETEROCYCLES | Abbott Laboratories (US) | 2010-01-06 | — | — | EP | disclosed |
| US-20080249305-A1 | Novel imidazole based heterocycles | ABBOTT LABORATORIES | 2008-10-09 | — | — | US | disclosed |
| US-20080249305-A1 | Novel imidazole based heterocycles | ABBOTT LABORATORIES | 2008-10-09 | — | — | US | disclosed |
| US-20080249305-A1 | Novel imidazole based heterocycles | ABBOTT LABORATORIES | 2008-10-09 | — | — | US | disclosed |
| US-20080242862-A1 | Novel imidazo based heterocycles | ABBOTT LABORATORIES | 2008-10-02 | — | — | US | disclosed |
| US-20080242862-A1 | Novel imidazo based heterocycles | ABBOTT LABORATORIES | 2008-10-02 | — | — | US | disclosed |
| US-20080242862-A1 | Novel imidazo based heterocycles | ABBOTT LABORATORIES | 2008-10-02 | — | — | US | disclosed |
| WO-2008118485-A1 | NOVEL IMIDAZO BASED HETEROCYCLES | ABBOTT LABORATORIES (US) | 2008-10-02 | — | — | WO | disclosed |
| WO-2008118485-A1 | NOVEL IMIDAZO BASED HETEROCYCLES | ABBOTT LABORATORIES (US) | 2008-10-02 | — | — | WO | disclosed |
| EP-1928237-A2 | NOVEL IMIDAZO BASED HETEROCYCLES | Abbott Laboratories (US) | 2008-06-11 | — | — | EP | disclosed |
| US-20070099925-A1 | Novel imidazo based heterocycles | ABBVIE INC. | 2007-05-03 | — | — | US | disclosed |
| US-20070099925-A1 | Novel imidazo based heterocycles | ABBVIE INC. | 2007-05-03 | — | — | US | disclosed |
| WO-2007028051-A2 | NOVEL IMIDAZO BASED HETEROCYCLES | ABBOTT LABORATORIES (US) | 2007-03-08 | — | — | WO | disclosed |
| WO-2007028051-A2 | NOVEL IMIDAZO BASED HETEROCYCLES | ABBOTT LABORATORIES (US) | 2007-03-08 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070099925-A1 | Novel imidazo based heterocycles | CDK4, CDK2, MAP3K19 | PRKD3 365/4885MAP4K4 23/4885MAPK9 189/4885 |
| US-20080242862-A1 | Novel imidazo based heterocycles | CDK4, CDK2, MAP3K15 | PRKD3 214/4885MAP4K4 22/4885MAPK9 274/4885 |
| US-20080249305-A1 | Novel imidazole based heterocycles | MAP3K5, MAP3K15, MAP3K20 | PRKD3 191/4885MAP4K4 25/4885MAPK9 249/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.